Bailard »

Editas Medicine shares owned by Bailard

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Bailard

Quarter filed Position value Share count Share price at filing
2024-03-31 $251k 34k 7.42
2021-06-30 $566k 10k 56.60

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus 2000 Val Etf (IWN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Inf Tech Etf (VGT)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Gilead Sciences (GILD)
Amazon (AMZN)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Editas Medicine

State Street Corporation
Vanguard Group
BlackRock
Deep Track Capital
Dimensional Fund Advisors
Pictet Asset Management Holding SA
Millennium Management
Geode Capital Management
Morgan Stanley
Goldman Sachs Group
Two Sigma Investments
Two Sigma Advisers
D. E. Shaw & Co
Qube Research & Technologies
Nuveen Asset Management

View all funds holding Editas Medicine